News Category
Quantum BioPharma's FDA clearance to advance Lucid-MS into Phase 2 trials marks a significant step toward a potential neuroprotective therapy for mult...
PX1 Research has expanded its US-based manufacturing to include seven-stage HPLC purity verification ensuring 99%+ purity on all research peptides, pr...
NanoViricides' regulatory approval to test its oral antiviral NV-387 in a Phase II Ebola trial in the DRC marks a potential shift toward more accessib...
Telomir Pharmaceuticals announced peer-reviewed preclinical data showing Telomir-Zn suppresses tumor growth in prostate and triple-negative breast can...
Quantum BioPharma's FDA approval to advance Lucid-MS into Phase 2 trials marks a pivotal step toward a potential neuroprotective therapy for multiple ...
Tonix Pharmaceuticals' Q2 2026 revenue surged to $13.5 million, driven by TONMYA's $11 million in sales, marking a significant commercial milestone an...
Tonix Pharmaceuticals' second-quarter revenue surged to $13.5 million, driven by TONMYA's $11 million in net sales, marking a significant commercial m...
Regentis Biomaterials is progressing its GelrinC cartilage regeneration technology through clinical trials, regulatory submissions, and European comme...
Quantum BioPharma advances a two-pronged approach to neurological health, with Lucid-MS for multiple sclerosis and unbuzzd for alcohol misuse, highlig...
Quantum BioPharma advances a two-pronged approach to neurological health, combining its investigational MS therapy Lucid-MS with its supplement unbuzz...
VERAXA Biotech's proprietary BiTAC platform and pipeline of ADCs and T-cell engagers position it to capitalize on significant pharmaceutical investmen...
A Spanish patient's brain cancer scare was ultimately diagnosed as pork tapeworm cysts, underscoring the importance of proper pork preparation and the...
VERAXA Biotech has advanced its VXA-222 bispecific antibody-drug conjugate program and expanded its patent portfolio, strengthening its position in ne...
A novel liquid biopsy offers a simpler method to predict immunotherapy response in advanced lung cancer patients, potentially aiding clinical trials f...
GeoVax announces completion of manufacturing, regulatory, clinical, and preclinical milestones for its GEO-MVA vaccine, positioning it for a pivotal P...
Onco-Innovations' integrated approach combining PNKP-targeted DDR inhibition, nanoparticle delivery, and AI could improve cancer treatment efficacy an...
Researchers at Nagoya University discovered that the ancient protein C3, when produced by tumor cells, boosts the effectiveness of immunotherapy, offe...
VolitionRx's new Capture-Seq technology, described in a peer-reviewed paper, isolates over 99% pure ctDNA, potentially enabling earlier cancer detecti...
Tonix Pharmaceuticals announced its participation in two key investor conferences, underscoring its commitment to advancing treatments for central ner...
VERAXA Biotech's VXA-222 bsADC program moves past discovery phase, and the company expands its IP portfolio with new patent filings, reinforcing its o...
NeuroThera Labs has initiated its Phase IIb clinical trial for SCI-110, a novel cannabinoid-based treatment for Tourette Syndrome, at the Yale Child S...
SRX Global's strategic investment in Vistagen Therapeutics underscores its commitment to unlocking shareholder value in undervalued biopharmaceutical ...
SRX Global's acquisition of a stake in Vistagen Therapeutics signals a strategic move to capitalize on undervalued neuroscience assets and engage with...
Quantum BioPharma's pilot MS imaging study with Massachusetts General Hospital has reached the halfway point in patient enrollment, with preliminary d...
Biotech Labz Supply Inc now offers 11 documented research peptides, including BPC-157 and Tesamorelin, to qualified researchers, emphasizing batch-spe...
Oncotelic Therapeutics' upcoming presentation at the OTCQB Virtual Investor Conference underscores its progress in clinical trials, platform validatio...
Tonix Pharmaceuticals announced FDA feedback supporting its planned adaptive Phase 2 field study of TNX-4800, a long-acting monoclonal antibody for Ly...
GeoVax underscores the strategic value of its MVA-based filovirus vaccine portfolio following independent research suggesting cross-reactive immune re...
Regentis Biomaterials is advancing GelrinC, a promising off-the-shelf cartilage repair treatment, to address a significant unmet need in orthopedics, ...
Quantum BioPharma's novel PET imaging technique, developed with Massachusetts General Hospital, shows encouraging preliminary results in distinguishin...
NeuroThera Labs' quantum platform successfully processes real-world clinical data through a complete hybrid quantum-classical workflow, highlighting i...
NeuroOne Medical Technologies released a white paper detailing its StereoCED™ platform, designed to address scalability challenges in brain drug deliv...
VERAXA Biotech has appointed Dr. Christoph Erkel as Chief Scientific Officer to lead scientific strategy for its proprietary BiTAC® cancer therapy pla...
Onco-Innovations closed a CAD$5 million private placement to fund its ONC010 program and SynoGraph platform development, addressing a critical need fo...
Lexaria Bioscience Corp. will effect a 1-for-15 reverse stock split effective August 3, 2026, to increase its share price above $1.00 and maintain its...
VolitionRx (NYSE American: VNRX) emphasizes mounting clinical evidence supporting its Nu.Q NETs assay as a biomarker for sepsis, with studies showing ...
Instinct Bio enters a strategic collaboration with INVITRX to manufacture and sell GENREVER cosmetic products in the U.S. and support regenerative med...
Renaissance BioScience Corp. appoints Dr. James Tansey, an experienced entrepreneur and academic, to its board to support growth and commercialization...
Dr. Sven K. Weber will succeed Adriaan Moelker as CEO of BRAIN Biotech AG on October 1, 2026, bringing extensive experience in the industrial enzyme b...
VERAXA Biotech announced it has expanded its patent portfolio to over 50 granted patents across 14 countries, protecting its BiTAC-TCE and BiTAC-ADC p...
MindBio Therapeutics has completed and delivered its first Edge AI intoxication and fatigue detection kiosk prototypes, potentially transforming workp...
VERAXA Biotech strengthens its scientific leadership by appointing antibody therapeutics specialist Dr. Christoph Erkel as CSO, as the company advance...
VERAXA Biotech AG filed new patent applications for its BiTAC-TCE and BiTAC-ADC platforms, expanding its IP portfolio to over 50 granted patents acros...
Greenland Mines announced a Canadian patent for Klotho-based gene therapies targeting neurodegenerative diseases, expanding its IP portfolio and advan...
Quantum BioPharma (QNTM) advances Lucid-MS toward Phase 2 trials for multiple sclerosis while generating revenue from its unbuzzd alcohol-metabolism p...
Shareholders of VERAXA Biotech voted with over 99.94% approval to adopt flexible corporate and financing structures, supporting the company's long-ter...
Greenland Mines Ltd. announced a Canadian patent for its Klotho-based gene therapy technology targeting neurodegenerative diseases, expanding its IP p...
NanoViricides has submitted an application to begin a Phase II trial of NV-387 Oral Gummies for Bundibugyo ebolavirus in the DRC, where no approved tr...
